General Information of Drug Therapeutic Target (DTT) (ID: TTK938H)

DTT Name Cytomegalovirus Deoxyribonucleic acid (CMV DNA)
Gene Name CMV DNA
DTT Type
Clinical trial target
[1]
UniProt ID
NOUNIPROTAC
TTD ID
T72737

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
ASP0113 DMVA8KU Cytomegalovirus infection 1D82 Phase 3 [1]
------------------------------------------------------------------------------------

References

1 VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection. Curr Opin Mol Ther. 2009 Oct;11(5):572-8.